LMR Partners’s Amicus Therapeutics FOLD Stock Holding History

LMR Partners’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,049,700	Closed	-$15.2M	–	1605
2026 Q1	$15.2M	Sell	1,049,700 -107,500	-9%	-$1.54M	0.03%	286
2025 Q4	$16.5M	Buy	+1,157,200	New	+$11.4M	0.03%	236
2021 Q1	–	Sell	-37,500	Closed	-$866K	–	992
2020 Q4	$866K	Buy	+37,500	New	+$767K	0.01%	299
2014 Q4	–	Sell	-27,459	Closed	-$163K	–	400
2014 Q3	$163K	Sell	27,459 -38,346	-58%	-$201K	0.01%	262
2014 Q2	$220K	Buy	+65,805	New	+$154K	0.02%	381

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

LMR Partners's FOLD Position: Q2 2026 in Review

LMR Partners sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,049,700 shares — an estimated $15.2M sold.

LMR Partners first reported a position in FOLD in Q2 2014 and held it in 5 quarters. The position peaked at $16.5M in Q4 2025. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

LMR Partners reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
LMR Partners sold 1,049,700 Amicus Therapeutics shares in Q2 2026, an estimated $15.2M.
LMR Partners first reported a position in Amicus Therapeutics in Q2 2014 and held it in 5 quarters.
LMR Partners's Amicus Therapeutics position peaked at $16.5M in Q4 2025.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.